[#item_full_content]
Month: October 2024
Human Papillomavirus (HPV)-induced Cancers: First Patient Enrolled in Phase I/IIa Clinical Trial for Lenti-HPV-07, the TheraVectys’ Therapeutic Vaccine Candidate Against Oropharyngeal and Cervical Cancers
[#item_full_content]PARIS–(BUSINESS WIRE)– #LentiHPV07–First patient enrolled in Phase I/IIa clinical trial for Lenti-HPV-07, the TheraVectys vaccine candidate…